R. Yoshikawa

发表

Associations of Sputum Biomarkers with Clinical Outcomes in People with Cystic Fibrosis

R. Szczesniak, J. Clancy, A. Quittner, 2022, medRxiv.

Effects of dapagliflozin in type 2 diabetes patients with fatty liver

Keigo Nakamura, T. Senoh, A. Yoshida, 2019, Japan Journal of Medicine.

Urinary PGDS levels are associated with vascular injury in type 2 diabetes patients.

Y. Urade, S. Miyamoto, H. Makino, 2007, Diabetes research and clinical practice.